Search PDMR transactions

Notifier
Name of person with notification obligation
BioAll AB
Reason for notification
Closely associated
Yes
Person discharging managerial responsibilities
Mathias Svahn
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
NextCell Pharma AB
Issuer’s LEI code
549300PBFGB5JYKXGA45
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
BTA NextCell Pharma BTA SE0015243407 Acquisition 15,000 Quantity 15.00 SEK 23/12/2020 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
NextCell Pharma BTA SE0015243407 Acquisition 23/12/2020 NASDAQ STOCKHOLM AB 15,000 (Quantity) 15.00 SEK
Total: 15,000
<< Back